The main advantage of proton therapy is its precision. Protons deposit most of their energy directly in the tumor with little ...

A new randomized clinical trial found that men with localized, intermediate‑risk prostate cancer recovered faster and ...

Radiation therapy (also called radiotherapy) uses high-energy beams or subatomic particles to damage the DNA inside prostate cancer cells. After enough damage, the cells cannot multiply, and they die.

Lutetium PSMA is administered via a drip and travels through the bloodstream seeking out prostate cancer cells before hitting them with targeted internal radiation, the University Hospitals Sussex NHS ...

Add Yahoo as a preferred source to see more of our stories on Google. For men facing the return of prostate cancer, a new combination therapy may offer a much longer break before the disease comes ...

Former prime minister Rishi Sunak has told the BBC that a targeted prostate cancer screening programme is needed urgently, and would "save countless lives". Sunak is an ambassador for the Prostate ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in ...

A common diabetes drug may mimic one key effect of exercise in prostate cancer patients. Researchers found metformin boosts an “exercise molecule” linked to appetite and weight control, even in those ...

Localized prostate cancer treatments include radical prostatectomy and focal therapy, with the latter targeting only cancerous areas to preserve healthy tissue. Focal therapy allows for active ...

Where previous research showed that PSMA therapy for prostate cancer can prolong the lives of patients who have exhausted all ...

A common diabetes medication could help men with prostate cancer who develop hormone therapy-related metabolic syndrome ...

If you or a loved one has been diagnosed with prostate cancer, you’re not alone—and you don’t have to wait long to take the next step. Whether you’re newly diagnosed, moving from active surveillance ...